Fecal Transplantation Associated With Improvements in IBS Symptoms
Although further study is required, pilot study results suggest that FMT may be a viable option for patients with IBS with significant bloating.
Inflammatory Bowel Diseases (IBD)
Ortikos Now Available for Mild to Moderate Crohn Disease
Ortikos, an anti-inflammatory corticosteroid, is approved as a once-daily treatment for mild to moderate active Crohn disease and for maintenance of clinical remission.
Discontinuation of Anti-TNF Agents More Likely in Patients With IBD Plus Anxiety, Mood Disorders
A team of investigators assessed the impact of anxiety and mood disorders on treatment with anti-tumor necrosis factor agents in individuals with inflammatory bowel disease.
Are There Sufficient Data to Confirm a Protective Role for Anti-TNF in COVID-19?
Authors of a letter to the editor raised questions about research that reported a protective role of anti-tumor necrosis factor therapy against COVID-19 among patients with inflammatory bowel disease.
Inflammatory Bowel Disease Associated With Higher Bacterial, Viral Meningitis Risk
Study finds that patients with IBD and 1 or more comorbidities are at increased risk for viral or bacterial meningitis.
Efficacy of Cannabinoids in Treating IBD Examined
Significant improvements in both clinical symptoms (ie, abdominal pain, general well-being, nausea, diarrhea, and decreased appetite) as well as QoL scores were observed with cannabinoids.
Assessing Symptoms, Blood, Stool Markers Best for Identifying Pediatric IBD
For pediatric patients with nonbloody diarrhea, evaluating symptoms plus blood and stool markers is the optimal test strategy for predicting inflammatory bowel disease.
Lower Risk for Relapse in Patients With Clinical and Endoscopic Remission of Ulcerative Colitis
A team of investigators conducted a systematic review to estimate the risk of relapse in patients with ulcerative colitis in remission.
Automated Ulcer Severity Grading Model Accurate in Crohn Disease
A team of investigators assessed the accuracy of a machine learning model in grading the severity of ulcers in patients with Crohn disease.
FDA Approves Adalimumab Biosimilar for IBD
The Food and Drug Administration (FDA) has approved Hulio® (adalimumab-fkjp; Mylan), a biosimilar to Humira® (adalimumab; AbbVie).
-
Loading...
-
Loading...
Next post in Inflammatory Bowel Diseases (IBD)
